🔎 Trials Near Me

መነሻ › ሊምፎማ › ኢሊኖይ › Chicago

በChicago፣ IL ለሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሊምፎማ የሚደረጉ 20 ጥናቶች በChicago እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07015242

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Chicago
እድሜ ከ18 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07509151

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Illinois Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06624085

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The David and Etta Jonas Center for Cellular Therapy, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

ተሳታዮችን በመፈለግ ላይ
  • Northwestern University Feinberg School of Medicine, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06960993

DALY II USA/ MB-CART2019.1 for DLBCL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Robert H Lurie Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT02332668

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Northwestern University, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT05131022

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Lurie Children's Hospital-Chicago, Chicago
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Northwestern Memorial Hospital, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
እድሜ ከ12 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT04830137

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ማርች 2026 · NCT07294677

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

ተሳታዮችን በመፈለግ ላይ
  • University of Chicago Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ፌብሩ 2026 · NCT05745285

Avo In R/R And Previously Untreated MCL

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Chicago Medical Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ጃንዩ 2026 · NCT04855695

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2025 · NCT04234048

በሌሎች ከተሞች ለሊምፎማ የሚደረጉ ጥናቶች

በChicago ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።